The association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities, according to a study published online Feb. 1 in eClinicalMedicine.
Yeon Mi Hwang, from the Institute for Systems Biology in Seattle, and colleagues conducted a retrospective cohort study to examine the impact of 12 selected IMIDs on adverse pregnancy outcomes. The analytic cohort included 365,075 people: 5,784 in the IMID group and 359,291 in the non-IMID group.
Source: Advances and More licensed by HealthDay
2024 © Advances and more. All Rights Reserved.